MSF and generic medicines

Skip to main content

Media room
Contact
msf.org

About us
About the Access Campaign

Media room

Latest news

Jobs
⚡Join our Global Day of Action!
Our work
Drug-resistant infections

HIV/AIDS

Hepatitis C

Patents and intellectual property

The Patent Oppositions Database

Spotlight on: Access to medicines in Europe

Spotlight on: RCEP trade agreement

Research and development

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

#NoMoreTears Johnson & Johnson Can You Hear Us?

Vaccines

A Fair Shot campaign
⚡ Join our Global Day of Action!
Get involved
Active campaigns

#NoMoreTears JOIN OUR GLOBAL DAY OF ACTION!

20 years of Advocacy in Action

Campaign success stories

A Fair Shot campaign

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)
Take Action

⚡Join our Global Day of Action!
Resources
Events

Feature stories

Infographics

Interviews

Letters

Opinion articles

Photo stories

Press releases

Publications

Fact sheets

Issue briefs

Reports

Report series

Technical briefs

All types

Research articles

Statements

Topic overview pages

Spotlight pages

Videos
⚡Join our Global Day of Action!

Media room
Contact
msf.org

About us
About the Access Campaign

Media room

Latest news

Jobs
⚡Join our Global Day of Action!
Our work
Drug-resistant infections

HIV/AIDS

Hepatitis C

Patents and intellectual property

The Patent Oppositions Database

Spotlight on: Access to medicines in Europe

Spotlight on: RCEP trade agreement

Research and development

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

#NoMoreTears Johnson & Johnson Can You Hear Us?

Vaccines

A Fair Shot campaign
⚡ Join our Global Day of Action!
Get involved
Active campaigns

#NoMoreTears JOIN OUR GLOBAL DAY OF ACTION!

20 years of Advocacy in Action

Campaign success stories

A Fair Shot campaign

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)
Take Action

⚡Join our Global Day of Action!
Resources
Events

Feature stories

Infographics

Interviews

Letters

Opinion articles

Photo stories

Press releases

Publications

Fact sheets

Issue briefs

Reports

Report series

Technical briefs

All types

Research articles

Statements

Topic overview pages

Spotlight pages

Videos
⚡Join our Global Day of Action!

Medicines shouldn’t be a luxury

Take action!

Get involved

J&J Can you hear us?

We’ve protested, we’ve sent letters, we challenged their monopoly, and we’re still waiting.

JOIN OUR GLOBAL DAY OF ACTION!

Search

Sort by

MSF and generic medicines

97% of the medicines MSF uses to treat people with HIV are generics made in India.

94% of the medicines MSF uses to treat people with HIV, TB, malaria and other infections diseases are generics.

2/3 of the medicines MSF uses to treat people with TB, HIV and malaria are generics made in India.

Don't miss out!

Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

Navigate

About the Access Campaign
1999-2019: 20 Years of Advocacy in Action
Contact us
Get involved
Our work
Resources
Search

Get updates

Sign up for our newsletter
Privacy & data protection information

Contact

MSF Access Campaign
Médecins Sans Frontières
Rue de Lausanne 78
P.O Box 1016
CH-1211 Geneva 1, Switzerland
Phone:+41 22 849 8484 Fax:+41 22 849 8404
E-mail: access(at)msf.org

Follow us on Twitter and Facebook

Facebook
Twitter
Vimeo

⚡Join our Global Day of Action!

⚡ Join our Global Day of Action!

⚡Join our Global Day of Action!

⚡Join our Global Day of Action!

⚡Join our Global Day of Action!

⚡ Join our Global Day of Action!

⚡Join our Global Day of Action!

⚡Join our Global Day of Action!

Medicines shouldn’t be a luxury

J&J Can you hear us?

MSF and generic medicines